Regencell Bioscience Holdings RGC Income Statement (2020-2026)

NASDAQ RGC
$10.45 +0.40 (+3.98%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Regencell Bioscience Holdings Quarterly Income Statement

Periods 8 quarters
Latest Jun 2026

Regencell Bioscience Holdings income statement data for the quarter ended Jun 2026. This income statement covers 8 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2020 Jun2021 Jun2022 Jun2023 Jun2024 Jun2025 Dec2025 Jun2026
Additional items
Shares Outstanding 10.00M10.00M12.81M13.01M13.01M494.49M494.49M494.60M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 10.00M10.00M12.81M13.01M13.01M494.49M494.49M494.60M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 10.00M10.00M13.01M13.01M13.01M494.49M495.88M

Regencell Bioscience Holdings Income Statement API

Pull Regencell Bioscience Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RGC&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY